Rethinking Synthetic Rationale Supervision for Disease Prediction
cs.AI, cs.CL, cs.LG
Submitted: 2026-06-09
Updated: 2026-10-20
License: http://creativecommons.org/licenses/by/4.0/
The gist: Supervised fine-tuning with synthetic rationales is widely assumed to improve clinical prediction by teaching models not only what to predict but why.
Terminology
Abstract
Supervised fine-tuning with synthetic rationales is widely assumed to improve clinical prediction by teaching models not only what to predict but why. We test this assumption on five-year Alzheimer's disease and related dementias (ADRD) prediction from longitudinal health histories. In this setting, we generate training rationales using the correct labels, then fine-tune models to output a rationale followed by a label. Across a large-scale controlled experiment of 504 configurations, we find that Rationale First SFT consistently and substantially hurts predictive performance relative to Label Only fine-tuning. The degradation persists across model families and data scales, and is not resolved by using a reasoning-oriented base model. A fixed-protocol cardiovascular disease (CVD) validation reproduces similar findings. Crucially, the failure is not explained by poor rationale quality: human expert annotation confirms that the generated rationales are medically accurate and faithfully grounded in patient-specific evidence, and few-shot experiments show that the same rationales improve performance when used as inference-time demonstrations rather than training targets. A simple label-ordering intervention clarifies the mechanism: placing the prediction before the same rationale restores predictive performance. This suggests that conditioning predictions on generated rationales contributes to the degradation. We hope our work paves the way toward a more precise understanding of when and how rationale-based supervision helps and when it does not, guiding the responsible development of language models for high-stakes clinical prediction.
Related papers
- MAVEN-T: Reinforced Heterogeneous Distillation for Real-Time Multi-Agent Trajectory Prediction
- Model Discovery Agent: LLM-assisted Bayesian experiment design for data-efficient discovery of mechanistic world models
- Agents' Last Exam
- The Clinician's Veto: Navigating Trust, Liability, and Uncertainty in Autonomous AI Prescribing
- MindHelper: Closed-Loop Embodied Mental-State Reasoning for Precision Intervention
- Incumbent Advantage: Brand Bias and Cognitive Manipulation Dynamics in LLM Recommendation Systems